Molecular Genetics, Risk Aversion, Return Perceptions, and Stock Market Participation November 18, 2018 Richard Sias, Laura Starks, and H. J. Turtle ABSTRACT Molecular genetic endowments related to cognition, personality, health, and body shape, established at least half a century prior, predict an individual’s risk aversion, beliefs regarding the distribution of expected equity returns, and equity market participation. We estimate that approximately half of the relation between equity market participation and risk aversion, or beliefs regarding the distribution of expected equity returns, arises from the portion of risk aversion, or beliefs, associated with these genetic endowments. Molecular genetic endowments are also strongly associated with many of the variables (e.g., trust, sociability, wealth) shown to explain heterogeneity in equity market participation. Preliminary draft, please do not quote. Sias is from the Department of Finance, Eller College of Management, University of Arizona, Tucson, Arizona, 85721; (520) 621-3462,
[email protected]. Starks is from the Department of Finance, McCombs School of Business, University of Texas at Austin, Austin, Texas 78712, (512) 471-5899,
[email protected]. Turtle is from the Department of Finance and Real Estate, College of Business, Colorado State University, Fort Collins, Colorado, 80523, (970) 491-3596,
[email protected]. Copyright © 2018 by the authors. Molecular Genetics, Risk Aversion, Return Perceptions, and Stock Market Participation “Oh there ain’t no other way, Baby I was born this way” -Lady Gaga Traditional utility maximizing theory concludes nearly all investors should invest some portion of their wealth in equity markets (e.g., Merton, (1969, 1971)) and most should hold almost all savings in equity (e.g., Heaton and Lucas (1997)).